Our roadmap towards commercialization includes:

• Development & Scale Up: Advance technical development and scale up of PBVs with our proprietary manufacturing technology.

• Preclinical Studies: Conduct in vivo studies to assess safety and efficacy of lead influenza PBVs.

• FDA IND Submission: Submit application for biological licensure to the FDA.

• GMP Manufacturing: Partner for GMP manufacturing of influenza PBVs.

• Phase I Clinical Trial: Conduct first human trial to evaluate safety and efficacy of influenza PBVs.